These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 31921188)

  • 1. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4
    Toor SM; Murshed K; Al-Dhaheri M; Khawar M; Abu Nada M; Elkord E
    Front Immunol; 2019; 10():2936. PubMed ID: 31921188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between Circulating and Tumor-Infiltrating CD4
    Al-Mterin MA; Murshed K; Elkord E
    Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between Circulating and Tumor-Infiltrating CD4
    Al-Mterin MA; Murshed K; Elkord E
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of different immune checkpoints-expressing CD4
    Al-Mterin MA; Murshed K; Alsalman A; Abu-Dayeh A; Elkord E
    BMC Cancer; 2022 Jun; 22(1):601. PubMed ID: 35655158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8
    Alsalman A; Al-Mterin MA; Murshed K; Alloush F; Al-Shouli ST; Toor SM; Elkord E
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral FoxP3
    Syed Khaja AS; Toor SM; El Salhat H; Ali BR; Elkord E
    Front Immunol; 2017; 8():619. PubMed ID: 28603527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer.
    Saleh R; Taha RZ; Toor SM; Sasidharan Nair V; Murshed K; Khawar M; Al-Dhaheri M; Petkar MA; Abu Nada M; Elkord E
    Cancer Immunol Immunother; 2020 Oct; 69(10):1989-1999. PubMed ID: 32393998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.
    Kim HR; Park HJ; Son J; Lee JG; Chung KY; Cho NH; Shim HS; Park S; Kim G; In Yoon H; Kim HG; Jung YW; Cho BC; Park SY; Rha SY; Ha SJ
    J Immunother Cancer; 2019 Dec; 7(1):339. PubMed ID: 31801611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients.
    Abd Al Samid M; Chaudhary B; Khaled YS; Ammori BJ; Elkord E
    Oncotarget; 2016 Mar; 7(12):14083-94. PubMed ID: 26885615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.
    Syed Khaja AS; Toor SM; El Salhat H; Faour I; Ul Haq N; Ali BR; Elkord E
    Oncotarget; 2017 May; 8(20):33159-33171. PubMed ID: 28388539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4
    Saleh R; Toor SM; Khalaf S; Elkord E
    Vaccines (Basel); 2019 Oct; 7(4):. PubMed ID: 31614877
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases.
    Kroemer M; Turco C; Spehner L; Viot J; Idirène I; Bouard A; Renaude E; Deschamps M; Godet Y; Adotévi O; Limat S; Heyd B; Jary M; Loyon R; Borg C
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma.
    Giraldo NA; Becht E; Vano Y; Petitprez F; Lacroix L; Validire P; Sanchez-Salas R; Ingels A; Oudard S; Moatti A; Buttard B; Bourass S; Germain C; Cathelineau X; Fridman WH; Sautès-Fridman C
    Clin Cancer Res; 2017 Aug; 23(15):4416-4428. PubMed ID: 28213366
    [No Abstract]   [Full Text] [Related]  

  • 15. Transcriptomic Profiling of Tumor-Infiltrating CD4
    Sasidharan Nair V; Toor SM; Taha RZ; Ahmed AA; Kurer MA; Murshed K; Soofi ME; Ouararhni K; Alajez NM; Abu Nada M; Elkord E
    Vaccines (Basel); 2020 Feb; 8(1):. PubMed ID: 32041340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical Expression of Immune Checkpoints; CTLA-4, LAG3, and TIM-3 in Cancer Cells and Tumor-infiltrating Lymphocytes (TILs) in Colorectal Carcinoma.
    Abdelrahman DI; Elhasadi I; Anbaig A; Bakry A; Mandour D; Wasefy T; Yehia AM; Alorini M; Shalaby AM; Yahia AIO; Alabiad MA
    Appl Immunohistochem Mol Morphol; 2024 Feb; 32(2):71-83. PubMed ID: 38108390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.
    Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD
    J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Pancreatic Carcinoma-Associated Fibroblasts Promote Expression of Co-inhibitory Markers on CD4
    Gorchs L; Fernández Moro C; Bankhead P; Kern KP; Sadeak I; Meng Q; Rangelova E; Kaipe H
    Front Immunol; 2019; 10():847. PubMed ID: 31068935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression of PD-1 with TIGIT or PD-1 with TIM-3 on tumor-infiltrating CD8
    Meyiah A; Mahmoodi Chalbatani G; Al-Mterin MA; Malekraeisi MA; Murshed K; Elkord E
    Int Immunopharmacol; 2023 Jun; 119():110207. PubMed ID: 37099940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly prevalent colorectal cancer-infiltrating LAP⁺ Foxp3⁻ T cells exhibit more potent immunosuppressive activity than Foxp3⁺ regulatory T cells.
    Scurr M; Ladell K; Besneux M; Christian A; Hockey T; Smart K; Bridgeman H; Hargest R; Phillips S; Davies M; Price D; Gallimore A; Godkin A
    Mucosal Immunol; 2014 Mar; 7(2):428-39. PubMed ID: 24064667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.